These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 24528085)

  • 1. Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs.
    Guan YP; Yang XX; Yao GY; Qiu F; Chen J; Chen LJ; Ye CS; Li M
    Asian Pac J Cancer Prev; 2014; 15(1):85-91. PubMed ID: 24528085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
    Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in estrogen-related genes and the risk of breast cancer among Han Chinese women.
    Sun MY; Du HY; Zhu AN; Liang HY; de Garibay GR; Li FX; Li M; Yang XX
    Int J Mol Sci; 2015 Feb; 16(2):4121-35. PubMed ID: 25689428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
    Couch FJ; Gaudet MM; Antoniou AC; Ramus SJ; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; Wang X; Kirchhoff T; McGuffog L; Barrowdale D; Lee A; Healey S; Sinilnikova OM; Andrulis IL; ; Ozcelik H; Mulligan AM; Thomassen M; Gerdes AM; Jensen UB; Skytte AB; Kruse TA; Caligo MA; von Wachenfeldt A; Barbany-Bustinza G; Loman N; Soller M; Ehrencrona H; Karlsson P; ; Nathanson KL; Rebbeck TR; Domchek SM; Jakubowska A; Lubinski J; Jaworska K; Durda K; Zlowocka E; Huzarski T; Byrski T; Gronwald J; Cybulski C; Górski B; Osorio A; Durán M; Tejada MI; Benitez J; Hamann U; Hogervorst FB; ; van Os TA; van Leeuwen FE; Meijers-Heijboer HE; Wijnen J; Blok MJ; Kets M; Hooning MJ; Oldenburg RA; Ausems MG; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Jacobs C; Eeles RA; Adlard J; Davidson R; Eccles DM; Cole T; Cook J; Paterson J; Brewer C; Douglas F; Hodgson SV; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Side LE; ; Bove B; Godwin AK; Stoppa-Lyonnet D; ; Fassy-Colcombet M; Castera L; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Bressac-de Paillerets B; Caron O; Pujol P; Coupier I; Delnatte C; Akloul L; Lynch HT; Snyder CL; Buys SS; Daly MB; Terry M; Chung WK; John EM; Miron A; Southey MC; Hopper JL; Goldgar DE; Singer CF; Rappaport C; Tea MK; Fink-Retter A; Hansen TV; Nielsen FC; Arason A; Vijai J; Shah S; Sarrel K; Robson ME; Piedmonte M; Phillips K; Basil J; Rubinstein WS; Boggess J; Wakeley K; Ewart-Toland A; Montagna M; Agata S; Imyanitov EN; Isaacs C; Janavicius R; Lazaro C; Blanco I; Feliubadalo L; Brunet J; Gayther SA; Pharoah PP; Odunsi KO; Karlan BY; Walsh CS; Olah E; Teo SH; Ganz PA; Beattie MS; van Rensburg EJ; Dorfling CM; Diez O; Kwong A; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Heidemann S; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Fiebig B; Heinritz W; Caldes T; de la Hoya M; Muranen TA; Nevanlinna H; Tischkowitz MD; Spurdle AB; Neuhausen SL; Ding YC; Lindor NM; Fredericksen Z; Pankratz VS; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Bernard L; Viel A; Giannini G; Varesco L; Radice P; Greene MH; Mai PL; Easton DF; Chenevix-Trench G; ; Offit K; Simard J;
    Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):645-57. PubMed ID: 22351618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
    Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
    J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common variant in the SIAH2 locus is associated with estrogen receptor-positive breast cancer in the Chinese Han population.
    Zhang B; Li Y; Zheng X; Zuo X; Zhou F; Liang B; Zhu J; Li P; Ding Y; Huang Z; Wang B; Chen Z
    PLoS One; 2013; 8(11):e79365. PubMed ID: 24244489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population.
    He Y; Liu H; Chen Q; Sun X; Liu C; Shao Y
    Tumour Biol; 2016 Jul; 37(7):9739-44. PubMed ID: 26803517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study confirms two susceptibility loci for breast cancer in Chinese Han women.
    Xu M; Xu Y; Chen M; Li Y; Li W; Zhu J; Zhang M; Chen Z; Zhang X; Liu J; Zhang B
    Breast Cancer Res Treat; 2016 Oct; 159(3):433-42. PubMed ID: 27572337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of NR5A2 and RYR2 3'UTR polymorphisms on the risk of breast cancer in a Chinese Han population.
    Wei Y; Wang X; Zhang Z; Zhao C; Chang Y; Bian Z; Zhao X
    Breast Cancer Res Treat; 2020 Aug; 183(1):1-8. PubMed ID: 32572717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of multiple genetic variants with breast cancer susceptibility in the Han Chinese population.
    Li X; Zou W; Liu M; Cao W; Jiang Y; An G; Wang Y; Huang S; Zhao X
    Oncotarget; 2016 Dec; 7(51):85483-85491. PubMed ID: 27863437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MHC class-III gene polymorphisms with ER-positive breast cancer in Chinese Han population.
    Pan Q; Ning Y; Chen LZ; Zhang S; Liu ZZ; Yang XX; Wei W; Wei H; Li QG; Yue HN; Wang JX
    Genet Mol Res; 2012 Dec; 11(4):4299-306. PubMed ID: 23079975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.
    Liang J; Chen P; Hu Z; Shen H; Wang F; Chen L; Li M; Tang J; Wang H; Shen H
    Breast Cancer Res Treat; 2010 Nov; 124(1):237-41. PubMed ID: 20213080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
    Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
    Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer].
    Chen Q; He Y; Liu C; Liu H; Sun X; Shao Y; Huang T; Xu B
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2783-6. PubMed ID: 26711978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association and interaction of myopia with SNP markers rs13382811 and rs6469937 at
    Li J; Jiao X; Zhang Q; Hejtmancik JF
    Mol Vis; 2017; 23():588-604. PubMed ID: 28848321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.
    Wang Y; Yang SH; Hsu PW; Chien SY; Wang CQ; Su CM; Dong XF; Zhao YM; Tang CH
    Medicine (Baltimore); 2019 Nov; 98(44):e17854. PubMed ID: 31689877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of breast cancer susceptibility loci in Chinese women.
    Long J; Shu XO; Cai Q; Gao YT; Zheng Y; Li G; Li C; Gu K; Wen W; Xiang YB; Lu W; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2357-65. PubMed ID: 20699374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
    Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
    Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
    Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
    Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.